$0.00
(0.00%
) Quote detailsUSD
( 0.00%
At Close (As of Jan 1, 1970)
$562.77M
Market Cap
-
P/E Ratio
-3.52
EPS
$28.67
52 Week High
$6.10
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Bicycle Therapeutics Ltd (BCYC) is a pioneering clinical-stage biopharmaceutical company based in Cambridge, UK, focused on innovating drug therapies using its proprietary bicyclic peptide platform. The company aims to address unmet medical needs across various disease areas, particularly in oncology and beyond, leveraging its unique approach to drug design. With a strong pipeline of candidates in development, Bicycle Therapeutics is positioning itself as a key player in transforming treatment modalities for patients with complex conditions. The firm is committed to advancing its therapeutic candidates through the clinic to potentially reshape the standard of care.